Rapp R P, Bivins B A
Hosp Formul. 1983 Dec;18(12):1124-8.
The administration of intravenous fluids or drugs may allow particulate and microbiologic contamination to enter the bloodstream. Studies have implicated injected particles as a cause of postinfusion phlebitis. The process of manufacturing the infusion product will influence the type and quantify of injected particles. Particles greater than 8 microns are filtered by the lung, and depending on their reactivity, can cause pulmonary granulomas. Particles below 8 microns are initially filtered, cleared by phagocytosis, and ultimately migrate to the liver and spleen. Both nonvisible particles and microbial contaminants of fluids and drugs can be effectively removed by 0.45- or 0.22-micron in-line final filtration. When filters are employed, problems can occur, including air locking, clogging, and drug-binding. A knowledge of why and to what extent these problems can occur will allow in-line filters to be used effectively by health care practitioners.
静脉输注液体或药物可能会使微粒和微生物污染物进入血液循环。研究表明,注入的微粒是输液后静脉炎的一个原因。输液产品的生产过程会影响注入微粒的类型和数量。大于8微米的微粒会被肺部过滤,根据其反应性,可导致肺部肉芽肿。小于8微米的微粒最初会被过滤,通过吞噬作用清除,最终迁移至肝脏和脾脏。液体和药物中的不可见微粒和微生物污染物均可通过0.45微米或0.22微米的在线终端过滤有效去除。使用过滤器时可能会出现问题,包括空气栓塞、堵塞和药物结合。了解这些问题为何会发生以及发生的程度,将有助于医护人员有效使用在线过滤器。